Search research articles
Contact Us
Filters
Showing results (1-10 of 334) with videos related to
Page
of 34
Sort By:
European Urology
|
September 20, 2018
It Ain't Over Till the Fat Lady Sings: The POPSTAR Trial
Piet Ost
Nature Reviews. Urology
|
December 11, 2019
PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer
Piet Ost
European Urology Oncology
|
February 28, 2024
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
Thomas Zilli, Piet Ost
European Urology
|
May 28, 2019
Re: Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Boris Hadaschik, Piet Ost
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2024
PSMA PET-CT, When Seeing Becomes Improving
Piet Ost, Nicolas Mottet
European Urology
|
March 2, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30
Piet Ost, Pirus Ghadjar
Oncotarget
|
October 23, 2018
Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
Thomas Zilli, Piet Ost
European Urology
|
September 4, 2018
Current Insights in the Management of High-risk Prostate Cancer: Still More Questions than Answers
Valerie Fonteyne, Piet Ost
The Lancet. Oncology
|
July 31, 2025
Reflections on the PEACE V-STORM trial - Authors' reply
Piet Ost, Thomas Zilli,
European Urology
|
November 19, 2018
Re: [<sup>177</sup>Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study
Kathia De Man, Piet Ost
Page
of 34
Search research articles
Search
Showing results (1-10 of 334) with videos related to
Sort By:
Page
of 34
European Urology
|
September 20, 2018
It Ain't Over Till the Fat Lady Sings: The POPSTAR Trial
Piet Ost
Nature Reviews. Urology
|
December 11, 2019
PSMA PET-CT redefines nonmetastatic castration-resistant prostate cancer
Piet Ost
European Urology Oncology
|
February 28, 2024
Reply to Francesco Montorsi, Giorgio Gandaglia, Francesco Barletta, and Alberto Briganti's Letter to the Editor re: Piet Ost, Shankar Siva, Sugmund Brabrand, et al. PEACE V-Salvage Treatment of Oligorecurrent Nodal Prostate Cancer Metastases (STORM): Acute Toxicity of a Randomized Phase 2 Trial. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2023.09.007
Thomas Zilli, Piet Ost
European Urology
|
May 28, 2019
Re: Assessment of <sup>68</sup>Ga-PSMA-11 PET Accuracy in Localizing Recurrent Prostate Cancer: A Prospective Single-Arm Clinical Trial
Boris Hadaschik, Piet Ost
International Journal of Radiation Oncology, Biology, Physics
|
September 26, 2024
PSMA PET-CT, When Seeing Becomes Improving
Piet Ost, Nicolas Mottet
European Urology
|
March 2, 2016
Re: Christopher J.D. Wallis, Refik Saskin, Richard Choo, et al. Surgery Versus Radiotherapy for Clinically-localized Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol 2016;70:21-30
Piet Ost, Pirus Ghadjar
Oncotarget
|
October 23, 2018
Metastasis-directed therapy: a new standard for oligorecurrent prostate cancer?
Thomas Zilli, Piet Ost
European Urology
|
September 4, 2018
Current Insights in the Management of High-risk Prostate Cancer: Still More Questions than Answers
Valerie Fonteyne, Piet Ost
The Lancet. Oncology
|
July 31, 2025
Reflections on the PEACE V-STORM trial - Authors' reply
Piet Ost, Thomas Zilli,
European Urology
|
November 19, 2018
Re: [<sup>177</sup>Lu]-PSMA-617 Radionuclide Treatment in Patients with Metastatic Castration-resistant Prostate Cancer (LuPSMA Trial): A Single-centre, Single-arm, Phase 2 Study
Kathia De Man, Piet Ost
Page
of 34